Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This study evaluates the diagnostic performance and safety of [18F]PSMA-1007 PET/CT imaging
in patients with suspected recurrence of prostate cancer after previous definitive treatment.